PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2012. Start Trial.
Date Value
November 20, 2026 0.4829
November 19, 2026 0.4907
November 18, 2026 0.5452
November 17, 2026 0.5622
November 16, 2026 0.5953
November 13, 2026 0.6852
November 12, 2026 0.5497
November 11, 2026 0.6066
November 10, 2026 0.5494
November 09, 2026 0.5959
November 06, 2026 0.5836
November 05, 2026 0.5631
November 04, 2026 0.6051
November 03, 2026 0.575
November 02, 2026 0.6259
October 30, 2026 0.5819
October 29, 2026 0.5884
October 28, 2026 0.5416
October 27, 2026 0.5512
October 26, 2026 0.5321
October 23, 2026 0.5187
October 22, 2026 0.5038
October 21, 2026 0.4958
October 20, 2026 0.516
October 19, 2026 0.5178
Date Value
October 16, 2026 0.5366
October 15, 2026 0.5616
October 14, 2026 0.5333
October 13, 2026 0.5503
October 12, 2026 0.6051
October 09, 2026 0.6295
October 08, 2026 0.6537
October 07, 2026 0.6733
October 06, 2026 0.7237
October 05, 2026 0.6912
October 02, 2026 0.7001
October 01, 2026 0.6992
September 30, 2026 0.7687
September 29, 2026 0.7178
September 28, 2026 0.7089
September 25, 2026 0.726
September 24, 2026 0.689
September 23, 2026 0.6923
September 22, 2026 0.7377
September 21, 2026 0.7425
September 18, 2026 0.7288
September 17, 2026 0.7986
September 16, 2026 0.7705
September 15, 2026 0.8109
September 14, 2026 0.8748

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
PAVmed, Inc. 29.26
Owlet, Inc. 0.7149
Abbott Laboratories 3.724
Align Technology, Inc. 2.667
AngioDynamics, Inc. 1.386

PS Ratio Related Metrics

Price 0.1621
Earnings Yield -1.88K%
Market Cap 5.319M